Louis Libbrecht
- Hepatology top 0.1%
- Liver physiology and pathology 25
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Liver Disease and Transplantation 14
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 12
- Cancer Research top 2%
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 33
- Hepatitis B Virus Studies 16
- Surgery top 1%
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
- Organ Transplantation Techniques and Outcomes 11
- Co-authors
- Tania RoskamsValeer DesmetDavid CassimanFrederik NevensRita De VosChris VerslypeCarl DenefJacques Pirenne
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Journal of Hepatology (18 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (8 papers)The Journal of Pathology (7 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Louis Libbrecht
160 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hepatology 3.5k
- Oncology 2.0k
- Cancer Research 976
- Epidemiology 2.1k
- Surgery 2.3k
Countries citing papers authored by Louis Libbrecht
This map shows the geographic impact of Louis Libbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Libbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Libbrecht more than expected).
Fields of papers citing papers by Louis Libbrecht
This network shows the impact of papers produced by Louis Libbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Libbrecht. The network helps show where Louis Libbrecht may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Louis Libbrecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 9 | |
| 8 | Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patient. | 2020 | 14 |
| 9 | 2020 | 70 | |
| 10 | Endoscopic features, pathological correlates and possible origin of foveolar gastric metaplasia presenting as a duodenal polyp. | 2019 | 0 |
| 11 | 2017 | 12 | |
| 12 | 2015 | 9 | |
| 13 | 2010 | 49 | |
| 14 | 2009 | 149 | |
| 15 | DOUBLE BLIND RANDOMIZED PHASE II STUDY WITH RADIATION+5-FLUOROURACIL +/- CELECOXIB FOR RESECTABLE RECTAL CANCER | 2009 | 11 |
| 16 | 2008 | 56 | |
| 17 | 2008 | 30 | |
| 18 | Decreased multidrug resistance protein 1 (mdr1) expression in inflamed human intestinal epithelium | 2005 | 1 |
| 19 | The expression of P16 in liver cell dysplasia in human cirrhotic liver | 2000 | 3 |
| 20 | 2000 | 130 |
About Louis Libbrecht
Louis Libbrecht is a scholar working on Hepatology, Oncology, Cancer Research, Surgery and Epidemiology, having authored 170 papers that have together received 7.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (33 papers), Liver physiology and pathology (25 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Hepatitis B Virus Studies (16 papers), Liver Disease and Transplantation (14 papers), Drug Transport and Resistance Mechanisms (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Organ Transplantation Techniques and Outcomes (11 papers). The work is most often cited by research in Hepatology (3.5k citations), Oncology (2.0k citations), Cancer Research (976 citations), Epidemiology (2.1k citations) and Surgery (2.3k citations). Louis Libbrecht has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Tania Roskams, Valeer Desmet, David Cassiman, Frederik Nevens, Rita De Vos, Chris Verslype, Carl Denef, Jacques Pirenne, Sara Vander Borght and Pál Kaposi-Novák. Their work appears in journals such as Journal of Hepatology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, The Journal of Pathology, Hepatology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.